Franz, Peter 2017. Motorische Unruhe bei Demenz. NeuroTransmitter, Vol. 27, Issue. 3, p. 38.
Messinger-Rapport, Barbara J. Little, Milta O. Morley, John E. and Gammack, Julie K. 2017. Clinical Update on Nursing Home Medicine: 2016. Journal of the American Medical Directors Association, Vol. 17, Issue. 11, p. 978.
Nowrangi, Milap A Lyketsos, Constantine G and Rosenberg, Paul B 2017. Principles and management of neuropsychiatric symptoms in Alzheimer’s dementia. Alzheimer's Research & Therapy, Vol. 7, Issue. 1, p. 12.
Calvó-Perxas, Laia Turró-Garriga, Oriol Aguirregomozcorta, Maria Bisbe, Josep Hernández, Erélido López-Pousa, Secundino Manzano, Anna Palacios, Mónica Pericot-Nierga, Imma Perkal, Héctor Ramió, Lluís Vilalta-Franch, Joan and Garre-Olmo, Josep 2017. Psychotropic Drugs in Patients With Alzheimer's Disease: A Longitudinal Study by the Registry of Dementias of Girona (ReDeGi) in Catalonia, Spain. Journal of the American Medical Directors Association, Vol. 15, Issue. 7, p. 497.
Tampi, Rajesh R. and Tampi, Deena J. 2017. Efficacy and Tolerability of Benzodiazepines for the Treatment of Behavioral and Psychological Symptoms of Dementia. American Journal of Alzheimer's Disease & Other Dementias®, Vol. 29, Issue. 7, p. 565.
2017. Management of non-cognitive symptoms associated with dementia. Drug and Therapeutics Bulletin, Vol. 52, Issue. 10, p. 114.
Ballard, Clive and Corbett, Anne 2017. Agitation and aggression in people with Alzheimerʼs disease. Current Opinion in Psychiatry, Vol. 26, Issue. 3, p. 252.
Boot, Brendon P. McDade, Eric M. McGinnis, Scott M. and Boeve, Bradley F. 2017. Treatment of Dementia With Lewy Bodies. Current Treatment Options in Neurology, Vol. 15, Issue. 6, p. 738.
Corbett, Anne Smith, Jessica Creese, Byron and Ballard, Clive 2017. Treatment of Behavioral and Psychological Symptoms of Alzheimer’s Disease. Current Treatment Options in Neurology, Vol. 14, Issue. 2, p. 113.
Volicer, Ladislav 2017. Antipsychotics Do Not Have To Be Used “Off Label” in Dementia. Journal of the American Medical Directors Association, Vol. 13, Issue. 6, p. 495.
Yeh, Yi-Chun and Ouyang, Wen-Chen 2017. Mood stabilizers for the treatment of behavioral and psychological symptoms of dementia: An update review. The Kaohsiung Journal of Medical Sciences, Vol. 28, Issue. 4, p. 185.
Halink, Drieske A. Marijnissen, Radboud M. Schut, Annemarieke A. and Oude Voshaar, Richard C. 2017. Drug reaction with eosinophilia and systemic symptoms induced by carbamazepine: DRESSed to kill. General Hospital Psychiatry, Vol. 33, Issue. 4, p. 412.e5.
Johnell, Kristina and Fastbom, Johan 2017. Antiepileptic drug use in community-dwelling and institutionalized elderly: a nationwide study of over 1 300 000 older people. European Journal of Clinical Pharmacology, Vol. 67, Issue. 10, p. 1069.
Mahmoud, Fade and Tampi, Rajesh R. 2017. Valproic Acid–Induced Parkinsonism in the Elderly: A Comprehensive Review of the Literature. The American Journal of Geriatric Pharmacotherapy, Vol. 9, Issue. 6, p. 405.
Restifo, Sam Lemon, Vivienne and Waters, Flavie 2017. Pharmacological Treatment of Behavioural and Psychological Symptoms of Dementia in Psychogeriatric Inpatient Units. Australasian Psychiatry, Vol. 19, Issue. 1, p. 59.
Rousseau, Thierry 2017. Maladie d'Alzheimer et troubles de la communication.
Gómez-Pavón, Javier González García, Paloma Francés Román, Inés Vidán Astiz, Maite Gutiérrez Rodríguez, José Jiménez Díaz, Gregorio Montero Fernández, Nuria Pilar Álvarez Fernández, Baldomero and Jiménez Páez, José María 2017. Recomendaciones en la prevención de reacciones adversas a medicamentos en personas mayores con demencia. Revista Española de Geriatría y Gerontología, Vol. 45, Issue. 2, p. 89.
Hort, J. O’Brien, J. T. Gainotti, G. Pirttila, T. Popescu, B. O. Rektorova, I. Sorbi, S. and Scheltens, P. 2017. EFNS guidelines for the diagnosis and management of Alzheimer’s disease. European Journal of Neurology, Vol. 17, Issue. 10, p. 1236.
Hort, J. O'Brien, J. T. Gainotti, G. Pirttila, T. Popescu, B. O. Rektorova, I. Sorbi, S. and Scheltens, P. 2017. European Handbook of Neurological Management.
Ballard, Clive G. Gauthier, Serge Cummings, Jeffrey L. Brodaty, Henry Grossberg, George T. Robert, Philippe and Lyketsos, Constantine G. 2017. Management of agitation and aggression associated with Alzheimer disease. Nature Reviews Neurology, Vol. 5, Issue. 5, p. 245.
Objective: To review and summarize the currently available data on the use of anticonvulsant mood stabilizers (carbamazepine, valproic acid, gabapentin, lamotrigine, topiramate) in the treatment of behavioral and psychological symptoms of dementia (BPSD); to determine whether these medications can be recommended for routine clinical use.
Methods: Literature search in five databases (PubMed, MEDLINE, EMBASE, PsychINFO and COCHRANE collaboration) and analysis of the randomized controlled double-blinded clinical trials found therein.
Results: A total of seven RCTs were identified (two for carbamazepine and five for valproate). One study showed statistically significant improvement of BPSD in the medication group in comparison to the placebo group; five studies showed no significant differences; one study showed statistically significant worsening of the symptoms in the medication group vs. placebo. The majority of the studies reported significantly more frequent adverse effects in the medication group.
Conclusion: Although clearly beneficial in some patients, anticonvulsant mood stabilizers cannot be recommended for routine use in the treatment of BPSD at the present time.
This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
Email your librarian or administrator to recommend adding this journal to your organisation's collection.
Full text views reflects the number of PDF downloads, PDFs sent to Google Drive, Dropbox and Kindle and HTML full text views.
* Views captured on Cambridge Core between September 2016 - 22nd September 2017. This data will be updated every 24 hours.